Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pheon Therapeutics
Shasqi, Inc.
Tempus AI
Novartis
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
M.D. Anderson Cancer Center
NextCure, Inc.
Black Diamond Therapeutics, Inc.
Elevation Oncology
NantCell, Inc.
Fusion Pharmaceuticals Inc.
SCRI Development Innovations, LLC
pharmaand GmbH
Fate Therapeutics
Incyte Corporation
Novartis
National Institutes of Health Clinical Center (CC)
CureOne
Pfizer
Merck Sharp & Dohme LLC
Calando Pharmaceuticals
New Mexico Cancer Research Alliance
Schillerhoehe Hospital
Case Comprehensive Cancer Center
Cancer Research UK
Vanderbilt-Ingram Cancer Center